trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Oliveira CS et al. Effects of histone hyperacetylation on the preimplantation development of male and female bovine embryos. 2010 Reprod. Fertil. Dev. pmid:20591338
Suo L et al. Changes in acetylation on lysine 12 of histone H4 (acH4K12) of murine oocytes during maternal aging may affect fertilization and subsequent embryo development. 2010 Fertil. Steril. pmid:19285668
Xia J et al. Epigenetic modification of vomeronasal (V2r) precursor neurons by histone deacetylation. 2010 Neuroscience pmid:20594945
Tian F et al. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. 2010 Ann. N. Y. Acad. Sci. pmid:20633124
Rössler R et al. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. 2010 Neuroscience pmid:20643196
Hajji N et al. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide. 2010 Oncogene pmid:20118981
Suh HS et al. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. 2010 J Neuroimmune Pharmacol pmid:20157787
Crosson CE et al. Inhibition of histone deacetylase protects the retina from ischemic injury. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20164449
Ajiro K et al. Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivo. 2010 Cell Death Differ. pmid:20057502
Auzzas L et al. Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity. 2010 J. Med. Chem. pmid:21073160
Choi YS et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. 2010 J. Cell. Mol. Med. pmid:20070436
Lee KJ et al. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. 2010 Biochim. Biophys. Acta pmid:20080132
Li Y et al. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. 2010 Mol. Cancer pmid:20946668
Gupta PK et al. Inhibitors selective for HDAC6 in enzymes and cells. 2010 Bioorg. Med. Chem. Lett. pmid:20947351
Halili MA et al. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. 2010 J. Leukoc. Biol. pmid:20200406
Karagiannis TC et al. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. 2010 Aging (Albany NY) pmid:20930262
Reichrath S et al. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. 2010 J. Steroid Biochem. Mol. Biol. pmid:20206691
Milagre I et al. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 2010 J. Alzheimers Dis. pmid:20930312
Bertrand P Inside HDAC with HDAC inhibitors. 2010 Eur J Med Chem pmid:20223566
Kitano A et al. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. 2010 Mol. Vis. pmid:21203344
Sponziello M et al. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. 2010 J. Endocrinol. Invest. pmid:19794300
Wu P et al. Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. 2010 Cell Death Differ. pmid:19798105
Law AY and Wong CK Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. 2010 Exp. Cell Res. pmid:19786016
Pollack BP et al. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. 2009 May-Jun Photochem. Photobiol. pmid:19076306
Chen Z et al. BCL11A represses HBG transcription in K562 cells. 2009 Mar-Apr Blood Cells Mol. Dis. pmid:19153051
Wang L et al. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. 2009 Mar-Apr Immunol. Cell Biol. pmid:19172156
Allritz C et al. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. 2009 Jul-Aug Neurochem. Int. pmid:19428803
Deng G et al. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. 2009 Clin. Cancer Res. pmid:19223499
Sterthaus O et al. Evaluation of in vitro cultured rat oocytes, from different strains, by spindle morphology and maturation-promoting-factor activity combined with nuclear-transfer experiments. 2009 Cloning Stem Cells pmid:19751114
Wang X et al. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents. 2009 Cancer Res. pmid:19752087
Hirata H et al. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. 2009 Clin. Cancer Res. pmid:19755393
Noh EJ et al. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. 2009 Biochem. Biophys. Res. Commun. pmid:19038231
Kong X et al. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells. 2009 J. Mol. Cell. Cardiol. pmid:19041327
Rossi M et al. Caspase cleavage of Itch in chronic lymphocytic leukemia cells. 2009 Biochem. Biophys. Res. Commun. pmid:19073138
Kishigami S and Wakayama T Somatic cell nuclear transfer in the mouse. 2009 Methods Mol. Biol. pmid:19085136
Sibinga NE Stable protein, unstable plaque? 2009 J. Mol. Cell. Cardiol. pmid:19101562
Niu F et al. Trichostatin A enhances OGD-astrocyte viability by inhibiting inflammatory reaction mediated by NF-kappaB. 2009 Brain Res. Bull. pmid:19103266
Santiago A et al. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions. 2009 Cell Cycle pmid:19106612
Nakajima S et al. Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231. 2009 Oncol. Rep. pmid:19513516
Takaya T et al. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. 2009 Circ. J. pmid:19521018
Sugimura S et al. Interspecies somatic cell nucleus transfer with porcine oocytes as recipients: A novel bioassay system for assessing the competence of canine somatic cells to develop into embryos. 2009 Theriogenology pmid:19524287
Gregorie CJ et al. Restoration of immune response gene induction in trophoblast tumor cells associated with cellular senescence. 2009 J. Reprod. Immunol. pmid:19493573
Soriano FX et al. Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2. 2009 Epigenetics pmid:19430206
Dagtas AS et al. Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells. 2009 Int. Immunopharmacol. pmid:19664724
Carambula SF et al. Repression of induced apoptosis in the 2-cell bovine embryo involves DNA methylation and histone deacetylation. 2009 Biochem. Biophys. Res. Commun. pmid:19665989
Fujii K et al. Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells. 2009 Cell Prolif. pmid:19614672
Ai J et al. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. 2009 Mol. Endocrinol. pmid:19855091
Peng DF et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. 2009 Gut pmid:18664505
Fraczek J et al. Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors. 2009 Invest New Drugs pmid:18825314
Demircan B et al. Comparative epigenomics of human and mouse mammary tumors. 2009 Genes Chromosomes Cancer pmid:18836996